PT Ikapharmindo Putramas Tbk (ISX:IKPM) EBITDA Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Ikapharmindo Putramas Tbk EBITDA Margin %?

PT Ikapharmindo Putramas Tbk ISX:IKPM -1.09% EBITDA Margin % is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 665 Healthcare Providers & Services companies, PT Ikapharmindo Putramas Tbk ranks worse than 150375.79% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PT Ikapharmindo Putramas Tbk's EBITDA for the six months ended in . 20 was Rp0.00 Mil. PT Ikapharmindo Putramas Tbk's Revenue for the six months ended in . 20 was Rp0.00 Mil. Therefore, PT Ikapharmindo Putramas Tbk's EBITDA margin for the quarter that ended in . 20 was 0.00%.

PT Ikapharmindo Putramas Tbk  (ISX:IKPM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PT Ikapharmindo Putramas Tbk EBITDA Margin % Related Terms

PT Ikapharmindo Putramas Tbk EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PT Ikapharmindo Putramas Tbk's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Ikapharmindo Putramas Tbk EBITDA Margin % Chart

PT Ikapharmindo Putramas Tbk Annual Data
Trend
EBITDA Margin %

PT Ikapharmindo Putramas Tbk Semi-Annual Data
EBITDA Margin %

PT Ikapharmindo Putramas Tbk EBITDA Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, PT Ikapharmindo Putramas Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Ikapharmindo Putramas Tbk EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Ikapharmindo Putramas Tbk's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PT Ikapharmindo Putramas Tbk's EBITDA Margin % falls into.


PT Ikapharmindo Putramas Tbk EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PT Ikapharmindo Putramas Tbk's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

PT Ikapharmindo Putramas Tbk's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
PT Ikapharmindo Putramas Tbk (ISX:IKPM) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Ikapharmindo Putramas Tbk and its competitors. According to the industry distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 665 companies in the Healthcare Providers & Services industry.
Is PT Ikapharmindo Putramas Tbk's EBITDA Margin % too high?
PT Ikapharmindo Putramas Tbk's current EBITDA Margin % is 0.00%. Based on the distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does PT Ikapharmindo Putramas Tbk's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 665 companies for EBITDA Margin %. This places PT Ikapharmindo Putramas Tbk in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Ikapharmindo Putramas Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Ikapharmindo Putramas Tbk's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Ikapharmindo Putramas Tbk stock overvalued right now?
PT Ikapharmindo Putramas Tbk (ISX:IKPM) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Ikapharmindo Putramas Tbk (ISX:IKPM), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Ikapharmindo Putramas Tbk Business Description

Address Jalan Pulogadung Raya No 29, Kawasan Industri Pulogadung, Jakarta, IDN, 13930
PT Ikapharmindo Putramas Tbk is a factory and marketer of Pharmaceutical Products and Consumer Health Products located in Jakarta, Indonesia. Company has three reportable segments including non-pharma, pharma and contract manufacturing deriving key revenue from the Non- Pharma segment. It focuses on providing good quality and a diverse portfolio to the Indonesian market, with trusted brands in the Pharmaceutical Product Categories of Prescription Medicines, OTC, Nutraceuticals, Professional Hair Care Products and Baby Products.